Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1976 Apr 1;143(4):993–998. doi: 10.1084/jem.143.4.993

Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid

PMCID: PMC2190167  PMID: 56421

Abstract

Amyloid fibrils were studied from two different tissues of medullary carcinoma of the thyroid (MCT). The fibrils mainly consisted of a low molecular weight protein, AMCT, which was immunologically distinct and did not react with various antisera against known amyloid fibril proteins. A specific antiserum raised against the MCT amyloid proteins gave a reaction of identity with the degraded MCT amyloid fibrils from two patients, as well as with the isolated AMCT protein, but showed no reaction with other known amyloid proteins. The AMCT protein had a blocked N terminus, but the sequence analysis of a cyanogen bromide fragment revealed identity with human calcitonin in the 11 positions studied. Although the amino acid composition was similar, there were also distinct differences, and the mol wt of 5,700 daltons was considerably larger than that of calcitonin. For these reasons the AMCT protein may represent a prohormone of calcitonin.

Full Text

The Full Text of this article is available as a PDF (400.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Husby G., Natvig J. B., Sletten K. New, third class of amyloid fibril protein. J Exp Med. 1974 Mar 1;139(3):773–778. doi: 10.1084/jem.139.3.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Husby G., Sletten K., Michaelsen T. E., Natvig J. B. Amyloid fibril protein subunit, "protein AS": distribution in tissue and serum in different clinical types of amyloidosis including that associated with myelomatosis and Waldenström's macroglobulinamia. Scand J Immunol. 1973;2(4):395–404. doi: 10.1111/j.1365-3083.1973.tb02048.x. [DOI] [PubMed] [Google Scholar]
  3. Neher R., Riniker B., Rittel W., Zuber H. Menschliches Calcitonin. 3. Struktur von Calcitonin M un. Helv Chim Acta. 1968;51(8):1900–1905. doi: 10.1002/hlca.19680510811. [DOI] [PubMed] [Google Scholar]
  4. Pearse A. G., Ewen S. W., Polak J. M. The genesis of apudamyloid in endocrine polypeptide tumours: histochemical distinction from immunamyloid. Virchows Arch B Cell Pathol. 1972;10(2):93–107. doi: 10.1007/BF02899719. [DOI] [PubMed] [Google Scholar]
  5. Pras M., Schubert M., Zucker-Franklin D., Rimon A., Franklin E. C. The characterization of soluble amyloid prepared in water. J Clin Invest. 1968 Apr;47(4):924–933. doi: 10.1172/JCI105784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Sletten K., Husby G. The complete amino-acid sequence of non-immunoglobulin amyloid fibril protein AS in rheumatoid arthritis. Eur J Biochem. 1974 Jan 3;41(1):117–125. doi: 10.1111/j.1432-1033.1974.tb03251.x. [DOI] [PubMed] [Google Scholar]
  7. Swank R. T., Munkres K. D. Molecular weight analysis of oligopeptides by electrophoresis in polyacrylamide gel with sodium dodecyl sulfate. Anal Biochem. 1971 Feb;39(2):462–477. doi: 10.1016/0003-2697(71)90436-2. [DOI] [PubMed] [Google Scholar]
  8. Tager H. S., Steiner D. F. Isolation of a glucagon-containing peptide: primary structure of a possible fragment of proglucagon. Proc Natl Acad Sci U S A. 1973 Aug;70(8):2321–2325. doi: 10.1073/pnas.70.8.2321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Westermark P. Amyloid of medullary carcinoma of the thyroid; partial characterization. Ups J Med Sci. 1975;80(2):88–92. doi: 10.3109/03009737509178999. [DOI] [PubMed] [Google Scholar]
  10. Westermark P., Skinner M., Cohen A. S. The P-component of amyloid of human islets of langerhans. Scand J Immunol. 1975;4(1):95–97. doi: 10.1111/j.1365-3083.1975.tb02604.x. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES